Search
for
Sort by
Research 121–150 of 982
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
- Drug eruptions in dermatology
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Hormone therapy in acne
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Telogen Effluvium
- The Rotterdam Study: 2010 objectives and design update
- Lupus erythematosus: systemic and cutaneous manifestations
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse effects of common medications on male fertility
- Telogen effluvium
- Hair and scalp disorders in ethnic populations
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Secondary cicatricial and other permanent alopecias
- ADVANCES IN PSORIASIS THERAPY
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
- Transgender and Migraine
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Cutaneous Reactions to Drugs
- LUPUS ERYTHEMATOSUS AND THE SKIN